Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 65% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Wave Life Sciences Q3 net loss widens 15% to $61.91 million; Q3 revenue rises 73% to $13.16 million

By Public Technologies
  • Wave Life Sciences’ third-quarter 2026 net loss widened 15% year over year to $61.91 million.
  • Revenue climbed 73% year over year to $13.16 million.
  • Cash, cash equivalents and marketable securities totaled $431 million at September 30, with operations funded into the third quarter of 2028.
  • Planning is underway for WVE-006’s two-year AATD registrational trial, including a one-year interim analysis supporting potential accelerated approval.
  • The WVE-007 combination trial with tirzepatide is underway, with a post-incretin maintenance trial targeted to begin in the fourth quarter of 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wave Life Sciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610270730PRIMZONEFULLFEED9853687) on October 27, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.